Cefaclor
Sold as Adco-cefaclor, Adco-cefaclor bd, Adco-cefaclor p, Adco-cefaclor bd forte, Vercef for, Cefaclor biotech, Otoclor, Vercef mr, Cloracef, Ralclor, Cloracef p, Cloracef bd, Cloracef pf, Ralclor for, Cloracef mr
(6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 51039.
Background
Registration
- Applicants
- 8
- Registrations
- 27
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adcock ingram limitedCancelled | Adco-cefaclor, Adco-cefaclor bd, Adco-cefaclor p, Adco-cefaclor bd forte | 125, 187, 250, 375 mg, 500 | 290463, 290464, 290465, 290466, 290467, 290468, 290469 | S4 | None |
| Ranbaxy (SA) (Pty) LtdCancelled | Vercef for, Vercef mr | 187 mg/5 ml, 375 mg/5 ml, tablets | 300436, 300451, 310651 | S4 | None |
| Arya Pharma (Pty) Ltd | Cefaclor biotech | 250, 500 | 310102, 310103 | S4 | None |
| Garec (Pty) LtdCancelled | Otoclor | 250, 500 | 310104, 310105 | S4 | None |
| Medicine Developers International (Pty) Ltd | Cloracef | 250, 500 | 320212, 320213 | S4 | None |
| Innovata pharmaceuticals | Ralclor, Ralclor for | 125 mg/5 ml, 187 mg/5 ml, 250, 250 mg/5 ml, 375 mg/5 ml, 500 | 320220, 320221, 320442, 320443, 320444, 320445 | S4 | None |
| Unimed Healthcare (Pty) LtdCancelled | Cloracef p | 125 | 320438 | S4 | None |
| Dezzo Trading 392 (Pty) Ltd | Cloracef bd, Cloracef pf, Cloracef mr | 187, 250, 375, tablets | 320439, 320440, 320441, 320558 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adco-cefaclor 250 EACH CAPSULE CONTAINS CEFACLOR 250 mg | 250 | 29046329/20.1.1/0463 | Cancelled | S4 | None |
| Adco-cefaclor 500 EACH CAPSULE CONTAINS CEFACLOR 500 mg | 500 | 29046429/20.1.1/0464 | Cancelled | S4 | None |
| Adco-cefaclor bd tablets 375 MG EACH TABLET CONTAINS CEFACLOR 375 mg | 375 mgTablets | 29046529/20.1.1/0465 | Cancelled | S4 | None |
| Adco-cefaclor 125 p EACH 5 ml SUSPENSION CONTAINS CEFACLOR 125 mg | 125 | 29046629/20.1.1/0466 | Cancelled | S4 | None |
| Adco-cefaclor 250 p EACH 5 ml SUSPENSION CONTIANS CEFACLOR 250 mg | 250 | 29046729/20.1.1/0467 | Cancelled | S4 | None |
| Adco-cefaclor bd 187 EACH 5 ml SUSPENSION CONTAINS CEFACLOR 187 mg | 187 | 29046829/20.1.1/0468 | Cancelled | S4 | None |
| Adco-cefaclor bd forte 375 EACH 5 ml SUSPENSION CONTAINS CEFACLOR 375 mg | 375 | 29046929/20.1.1/0469 | Cancelled | S4 | None |
| Vercef granules for oral suspension 187 mg/5 ML EACH 5 ML CONTAINS CEFACLOR (MONOHYDRATE) EQUIVALENT TO 187 mg CEFACLOR ANHYDROUS | 187 mg/5 mlGranules oral suspension | 30043630/20.1.1/0436 | Cancelled | S4 | None |
| Vercef granules for oral suspension 375 mg/5 ML EACH 5 ml SUSPENSION CONTAINS CEFACLOR EQUIVALENT TO 375 mg CEFACLOR ANHYDROUS | 375 mg/5 mlGranules oral suspension | 30045130/20.1.1/0451 | Cancelled | S4 | None |
| Cefaclor 250 biotech EACH CAPSULE CONTAINS CEFACLOR 250,0 mg | 250 | 31010231/20.1.1/0102 | Registered | S4 | None |
| Cefaclor 500 biotech EACH CAPSULE CONTAINS CEFACLOR 500,0 mg | 500 | 31010331/20.1.1/0103 | Registered | S4 | None |
| Otoclor 250 EACH CAPSULE CONTAINS CEFACLOR 250,0 mg | 250 | 31010431/20.1.1/0104 | Cancelled | S4 | None |
| Otoclor 500 EACH CAPSULE CONTAINS CEFACLOR 500,0 mg | 500 | 31010531/20.1.1/0105 | Cancelled | S4 | None |
| Vercef mr tablets EACH TABLET CONTAINS CEFACLOR EQUIVALENT TO CEFACLOR ANHYDROUS 375 mg | Tablets | 31065131/20.1.1/0651 | Cancelled | S4 | None |
| Cloracef 250 EACH CAPSULE CONTAINS CEFACLOR (MONOHYDRATE) EQUIVALENT TO CEFACLOR 250,0 mg | 250 | 32021232/20.1.1/0212 | Registered | S4 | None |
| Cloracef 500 EACH CAPSULE CONTAINS CEFACLOR (MONOHYDRATE) EQUIVALENT TO CEFACLOR 500,0 mg | 500 | 32021332/20.1.1/0213 | Registered | S4 | None |
| Ralclor 250 capsules EACH CAPSULE CONTAINS CEFACLOR (MONOHYDRATE) EQUIVALENT TO CEFACLOR 250,0 mg | 250Capsules | 32022032/20.1.1/0220 | Registered | S4 | None |
| Ralclor 500 capsules EACH CAPSULE CONTAINS CEFACLOR (MONOHYDRATE) EQUIVALENT TO CEFACLOR 500,0 mg | 500Capsules | 32022132/20.1.1/0221 | Registered | S4 | None |
| Cloracef p 125 EACH 5,0 ml SUSPENSION CONTAINS CEFACLOR EQUIVALENT TO CEFACLOR ANHYDROUS 125,0 mg | 125 | 32043832/20.1.1/0438 | Cancelled | S4 | None |
| Cloracef bd 187 EACH 5,0 ml SUSPENSION CONTAINS CEFACLOR EQUIVALENT TO CEFACLOR ANHYDROUS 187,0 mg | 187 | 32043932/20.1.1/0439 | Registered | S4 | None |
| Cloracef pf 250 EACH 5,0 ml SUSPENSION CONTAINS CEFACLOR EQUIVALENT TO CEFACLOR ANHYDROUS 250,0 mg | 250 | 32044032/20.1.1/0440 | Registered | S4 | None |
| Cloracef bd 375 EACH 5,0 ml SUSPENSION CONTAINS CEFACLOR EQUIVALENT TO CEFACLOR ANHYDROUS 375,0 mg | 375 | 32044132/20.1.1/0441 | Registered | S4 | None |
| Ralclor granules for oral suspension 125 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS CEFACLOR EQUIVALENT TO CEFACLOR ANHYDROUS 125,0 mg | 125 mg/5 mlGranules oral suspension | 32044232/20.1.1/0442 | Registered | S4 | None |
| Ralclor granules for oral suspension 187 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS CEFACLOR EQUIVALENT TO CEFACLOR ANHYDROUS 187,0 mg | 187 mg/5 mlGranules oral suspension | 32044332/20.1.1/0443 | Registered | S4 | None |
| Ralclor granules for oral suspension 250 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS CEFACLOR EQUIVALENT TO CEFACLOR ANHYDROUS 250,0 mg | 250 mg/5 mlGranules oral suspension | 32044432/20.1.1/0444 | Registered | S4 | None |
| Ralclor granules for oral suspension 375 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS CEFACLOR EQUIVALENT TO CEFACLOR ANHYDROUS 375,0 mg | 375 mg/5 mlGranules oral suspension | 32044532/20.1.1/0445 | Registered | S4 | None |
| Cloracef mr tablets EACH TABLET CONTAINS CEFACLOR 375,0 mg | Tablets | 32055832/20.1.1/0558 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Cefaclor
S4: Cefaclor
Consolidated Schedules 06 July 2026, line 5689
Pharmacological class: Broad and medium spectrum antibiotics. (class 20.1.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.